会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 172. 发明公开
    • APPARATUS AND METHOD OF ENDOSCOPIC SUTURING
    • 内窥镜切割设备和方法
    • EP1802238A2
    • 2007-07-04
    • EP05812927.1
    • 2005-10-18
    • Temple University of the Commonwealth System of Higher Education
    • MILLER, Larry, S.
    • A61B17/04
    • A61B17/0401A61B17/0469A61B17/0487A61B2017/0409A61B2017/0417A61B2017/0445A61B2017/0458A61B2017/0461A61B2017/0464A61B2017/0488A61B2017/06052
    • An adjustable suture assembly is provided that may be employed in various surgical procedures to draw and/or hold tissue and/or muscle together. The suture assembly may include a suture lock or tensioner that is adjustably securable to two or more lengths of suture to provide a surgeon with an ability to maintain tissue or muscle in one secured position and subsequently readjust the suture assembly to maintain the tissue or muscle in a different secured position. The suture assembly may include two or more sutures having an anchor attached to an end of each suture for anchoring the suture to desired tissue or muscle. An endoscopic suturing device is provided to deliver and place two or more sutures in tissue or muscle during a surgical procedure. The suturing device may be configured to carry a plurlaity of sutures so that multiple sutures can be placed in tissue or muscle during a single intubation of the device. The suture assembly and suturing device may be employed with an endoscope to facilitate surgical treatment of obesity which involves narrowing and/or disabling the pyloric sphincter to reduce the rate of gastric emptying.
    • 提供可调整的缝合线组件,其可以用于各种外科手术中以将组织和/或肌肉牵引和/或保持在一起。 缝合线组件可以包括可调节地固定到两段或更多段缝合线的缝合线锁或张紧器,以使外科医生能够将组织或肌肉保持在一个固定位置,并且随后重新调整缝合线组件以将组织或肌肉保持在 一个不同的安全位置。 缝合线组件可以包括两根或更多根缝合线,该两根或更多根缝合线具有连接到每根缝合线的端部的锚固件,用于将缝合线锚定到期望的组织或肌肉。 提供内窥镜缝合装置以在手术过程中递送两根或更多根缝合线并将其放置在组织或肌肉中。 缝合装置可以被构造成携带多重缝合线,使得在装置的单次插管期间可以将多根缝合线放置在组织或肌肉中。 缝合线组件和缝合装置可以与内窥镜一起使用以促进对肥胖症的手术治疗,其涉及使幽门括约肌变窄和/或使其失能以降低胃排空速率。
    • 173. 发明授权
    • (E)-STYRYL SULFONE ANTICANCER AGENTS
    • (E) - 苯乙烯磺酸钠抗癌剂
    • EP1173160B1
    • 2005-06-22
    • EP00921553.4
    • 2000-03-31
    • Temple University of the Commonwealth System of Higher Education
    • REDDY, E., PremkumarREDDY, M., V., Ramana
    • A61K31/10C07C317/10C07C321/20C07C317/44
    • C07C317/18C07C317/10C07C317/44
    • (E)-styryl benzylsulfones of formula (I) are useful as anticancer agents wherein R1, R2, R3, and R4 are independently selected from the group consisting of hydrogen, fluoro, chloro, iodo, bromo, C1-C6 alkyl, C1-C4 alkoxy, nitro, cyano and trifluoromethyl, with the proviso that (a) R1, R2, and R3 not all hydrogen when R4 is 2-chloro or 4-chloro; (b) when R1 and R3 are hydrogen and R2 is 4-bromo or 4-chloro, then R4 may not be 4-chloro, 4-fluoro or 4-bromo; (c) when R1 and R3 are hydrogen and R2 is 4-fluoro, then R4 may not be 4-fluoro or 4-bromo; (d) when R1 is hydrogen, and R4 is 2-fluoro, the R2 and R3 may not be 4-fluoro; and (e) when R1 is hydrogen and R3 is 4-hydrogen, 4-chloro, 4-bromo, 4-methyl or 4-methoxy, and R4 is 2-hydrogen, 2-chloro, or 2-fluoro; then R2 may not be 4-hydrogen, 4-chloro, 4-fluoro, or 4-bromo.
    • (E) - 苯乙烯基苄基砜可用作抗癌剂,其中R 1,R 2,R 3和R 4独立地选自氢,氟,氯,碘,溴,C 1 -C 6烷基,C 1 -C 6烷基, C4烷氧基,硝基,氰基和三氟甲基,条件是(a)当R4是2-氯或4-氯时,R1,R2和R3不全是氢; (b)当R 1和R 3是氢并且R 2是4-溴或4-氯时,则R 4可以不是4-氯,4-氟或4-溴; (c)当R 1和R 3是氢并且R 2是4-氟时,则R 4可以不是4-氟或4-溴; (d)当R 1为氢且R 4为2-氟时,R 2和R 3可以不是4-氟; 和(e)当R 1为氢且R 3为4-氢,4-氯,4-溴,4-甲基或4-甲氧基,且R 4为2-氢,2-氯或2-氟时; 那么R2可能不是4-氢,4-氯,4-氟或4-溴。